S ince its introduction in 1932 [1] . transurethral resection of prostate (TUR-P) has been the gold standard treatment for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/LUTS). However, recent advances in minimally invasive prostatic procedures resulted in a decline in the TUR-P in the past decade [2] . Especially, photoselective vaporization of the prostate technique (PVP, GreenLight laser prostatectomy) has become an alternative option for BPH/LUTS, after its launch in 1998 [3] . The efficacy and safety of GreenLight PVP is comparable to 
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Abstract TUR-P and it is superior to TUR-P in terms of the duration of hospital stay and catheterization time [4, 5] .
Several studies have demonstrated the benefits of this system in terms of the intraoperative and post-operative course of patients [6, 7] . Since the majority of men with BPH/LUTS are older than 50 years, they may exhibit significant comorbid medical conditions that place them at a high anesthetic risk. Although endoscopic transurethral [8] , retropubic [9] , perineal [10] , or combinations of transurethral and perineal [11] local prostate anesthetic blocks have been suggested for prostatic surgery, they are not commonly adopted by urologists. However, increasing pressure from health-care providers to reduce medical costs has led to shift of research on urological procedures from the hospital to outpatient surgery centers and to adopting local anesthesia wherever possible.
This study aimed to assess the feasibility of using local anesthesia during the 180-Watt GreenLight® PVP procedure among patients who were unsuitable for general or regional anesthesia.
Materials and Methods
This study protocol has been approved by the institutional review board. After obtaining their informed consent, 52 patients who underwent PVP using the 180-Watt GreenLight system (American Medical Systems, Minnetonka, MN, USA) at our institution under periprostatic block between December 2013 and August 2015 have been included into this prospective study. Inclusion criteria: Patients with an indication for BPH operation and patients with comorbidity that would not be able to tolerate general anesthesia were included in the study. All patients completed an International Prostate Symptom Score (IPSS) and underwent uroflowmetric evaluation to determine the maximum flow rate (Qmax). Prostate volumes were measured by transrectal ultrasonography, and prostate-specific antigen (PSA) levels were analyzed.
Before surgery, a 27-gauge needle was inserted into the perineal region and the transperineal tract, leading to the prostate anesthetized with 5 cc of bupivacaine hydrochloride with adrenalin (5 mg/ml) (Marcain, AstraZeneca, Cambridge, UK). Subsequently, 20 ml of bupivacaine hydrochloride with adrenalin (5 mg/ml) was injected into the periprostatic area through a 22-gauge Spinocan® needle (B. Braun Medical Inc., PA, USA), which was guided into the plane between the rectum and prostate under the guidance of an index finger inserted in the rectum (Fig. 1 ). In addition, all patients received 10 cc of intraurethral 2% li-docaine gel (Cathejell® BioSyent Pharma Inc., Toronto, ON, Canada). To retain consistency, all periprostatic blocks and PVP operations were performed by the same urologist (OOC). Pain was assessed using the visual analog scale (VAS) [12] immediately after the procedure. 3 months after surgery, patients were reassessed and their IPSS, Qmax, post-void residual, and PSA levels were reanalyzed.
The statistical analyses were carried out using the Statistical Package for the Social Sciences Version 20 (SPSS, Chicago, IL, USA). In addition to the descriptive analyses, paired t-test was used to compare the pre-operative and post-operative variables. Statistical significance level was set as p<0.05.
Results
Mean patient age was 74.88±7.16 (range: 61-90) years and the mean PSA level was 1.74±0.46 (0.65-2.46) ng/dl. Of the patients, 44 (84.62%), 30 (57.69%), 17 (32.69%), and 4 (7.69%) had hypertension, diabetes mellitus, coronary artery disease, and chronic obstructive pulmonary disease, respectively.
The mean operation, hospitalization, and catheterization time of the patients are demonstrated in Table 1 . All operations were successfully completed without requiring conversion to general anesthesia. No perioperative complications were recorded. The majority of patients did not exhibit any evidence of pain during the procedure (46 of 52 patients had VAS of 0), with mean VAS score of 0.40±1.27 (range: 0-6). However, 38.5% (20/52) of patients described the feeling of urgency and bladder fullness, which were relieved by the continuous low-pressure irrigation technique.
In the post-operative 3 rd month, PVP resulted in a significant improvement in IPSS (28.6±3.83 vs. 10.73±2.62, p<0.0001) and Qmax (6.88±1.1 vs. 23.87±2.8, p<0.0001). There is not any complication during follow-up.
Discussion
The findings of our study demonstrate that injecting local anesthetic into the periprostatic area and prostate capsule provides sufficient anesthesia for the 180-Watt GreenLight PVP procedure among patients who are unsuitable for general or regional anesthesia. No patient in our study required additional anesthetic interventions, and the majority of the patients reported VAS scores of zero (no pain). The efficacy of the PVP procedure was observed during the 3rd month follow-up when significantly improved IPSS and Qmax values were recorded. None of the patients experienced any post-operative complication during the follow-up period, which confirms the safety of the 180-Watt GreenLight PVP procedure performed under local anesthesia.
To the best of our knowledge, the idea of performing TUR-P under local anesthesia was initially proposed by Moffat, who operated 18 BPH patients under after lidocaine infiltration into the prostate in 1977 [10] . Moffat reported that modest doses of intravenous sedatives were required in a few cases, proving that this method of anesthesia is safe and effective. In 1984, Orandi emphasized the importance of using local anesthesia for urological endoscopic surgeries such as transurethral incision and resection of the prostate, visual urethrotomy, ureteral meatotomy, and resection of primary and recurrent bladder tumors [8] . In a similar study, Issa et al. [13] performed transperineal prostatic block in 43 patients who underwent interstitial laser coagulation of the prostate in either an outpatient or office setting. These authors confirmed that the majority of their patients tolerated the procedure, concluding that perineal prostatic block is a safe, economical, and effective anesthesia technique for minimally invasive prostate surgeries.
At present, there are three GreenLight laser systems available; 80-Watt, 120-Watt, and 180-Watt. The 180-Watt GreenLight laser systems have greater maximum power output, advanced fiber design, and improved energy-tissue interaction, compared with the previous PVP technologies [5] . Although the feasibility of using local anesthesia during 80-Watt PVP has been previously evaluated [6] , there are no such data for 180-Watt PVP. The fibers used in this new system are water cooled, which reduces laser energy in case of overheating [14, 15] . This technology may explain the more favorable outcome of pain recorded for our patients compared with those in previous studies, in which prostatic block was used for transurethral prostate procedures.
This study is not without limitations. First of all, having a comparative group of patients who undergo 180-Watt PVP procedure under general or regional anesthesia would support the reliability of our findings. Similarly, including higher number of patients would significantly improve the quality of our study. Conducting cost-effectiveness analysis to compare the costs of general/regional anesthesia and local anesthesia would confirm the economic benefits of using prostatic block for endoscopic prostate procedures. Prostate volume reduction and PSA reduction have not been evaluated. Finally, conducting the current study in a single center may be considered as another limitation. However, we believe that our results may construct a basis for conducting larger, multicenter, and controlled clinical trials. After all, this anesthesia technique has the potential to reduce the cost, time, operating room resources, and paperwork associated with general and regional anesthesia.
Conclusion
Periprostatic block appears to be a feasible and safe alternative to general or regional anesthesia during PVP using the 180-Watt GreenLight system. This type of anesthesia may be preferred for elderly patients with BPH/LUTS who cannot tolerate general and/or regional anesthesia due to age-related comorbidities. 
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